PONOI Capital, L.P. is Director & 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 3 open-market trades across 1 company since 2020, most recently 2022-05-20.
CIK 0001707230
3 open-market purchases totalling $2.0M since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NGM | 48,987 | $75K |
Shares reported on the most recent Form 4, priced at the 2022-05-23 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.